Herpes simplex virus type-2 (HSV-2) suppressive therapy to reduce genital and plasma HIV-1 RNA: overview of ANRS1285 trials, potential mechanisms and future interventions.

• From: Department for International Development
• Published: 1 January 2006

• Country: Burkina Faso
• Document Type: Conference Paper
• Theme: Health
• Authors: Mayaud, P., Weiss, H.A., Nagot, N., Ouedraogo, A., van de Perre, P., Vergne, L., Konate, I., Sanon, A.

Citation

Mayaud, P.; Ouedraogo, A.; Nagot, N.; Konate, I.; Vergne, L.; Weiss, H.A.; Sanon, A.; van de Perre, P. Herpes simplex virus type-2 (HSV-2) suppressive therapy to reduce genital and plasma HIV-1 RNA: overview of ANRS1285 trials, potential mechanisms and future interventions. (2006)

Links

Herpes simplex virus type-2 (HSV-2) suppressive therapy to reduce genital and plasma HIV-1 RNA: overview of ANRS1285 trials, potential mechanisms and future interventions.

Published 1 January 2006